Kümmerer Klaus, Alexy Radka, Hüttig Jana, Schöll Alice
Institut für Umweltmedizin und Krankenhaushygiene, Universitätsklinikum Freiburg, Hugstetterstrasse 55, Freiburg i.Br. D-79106, Germany.
Water Res. 2004 Apr;38(8):2111-6. doi: 10.1016/j.watres.2004.02.004.
Pharmaceuticals are designed and used because of their specific biological effects. Over the past decade, compounds from various classes of pharmaceuticals have been detected in the environment. Concern has grown about the adverse effects pharmaceuticals in the environment might potentially have on human and ecological health. A sound risk assessment is therefore urgently needed for pharmaceuticals. Standardized tests for assessing the effects of chemicals on environmental organisms are widely used for this purpose. However it is questionable whether classical standardized tests give reliable data needed for environmental risk assessment. In this study we investigated the suitability of the respiration inhibition test OECD 209 for the assessment of the effects of antibiotics, disinfectants and cytotoxics on sewage sludge bacteria. We found that inhibition concentrations can strongly depend on the test period and the type of compound. We conclude that tests to assess the effects of pharmaceuticals on environmental organisms such as bacteria have to be evaluated before their results can be used in environmental risk assessment.
药物因其特定的生物学效应而被设计和使用。在过去十年中,已在环境中检测到各类药物的化合物。人们越来越担心环境中的药物可能对人类和生态健康产生不利影响。因此,迫切需要对药物进行合理的风险评估。为此,广泛使用评估化学品对环境生物影响的标准化测试。然而,经典的标准化测试能否提供环境风险评估所需的可靠数据仍值得怀疑。在本研究中,我们调查了经合组织209号呼吸抑制试验对于评估抗生素、消毒剂和细胞毒性药物对污水污泥细菌影响的适用性。我们发现抑制浓度可能强烈取决于测试周期和化合物类型。我们得出结论,在将评估药物对细菌等环境生物影响的测试结果用于环境风险评估之前,必须对这些测试进行评估。